Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 28, 2025 9:00 A.M.
Form:
S-3
CIK:
0001971532
Company Name:
Telomir Pharmaceuticals, Inc.
File Number:
333-284990